Outcomes of adjuvant oral versus intravenous fluoropyrimidines for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
Jiaqiang Zhang, Yu Chun Yen, Lei Qin, Chia Lun Chang, Kevin Sheng Po Yuan, Alexander T.H. Wu, Szu Yuan Wu
研究成果: 雜誌貢獻 › 文章 › 同行評審
1
引文
斯高帕斯(Scopus)